Asian expert recommendation on management of skin and mucosal effects of radiation, with or without the addition of cetuximab or chemotherapy, in treatment of head and neck squamous cell carcinoma

PO-077: Cetuximab Plus Radiotherapy for Chinese Patients with Locally Advanced Head and Neck Cancer

(2015) L. Gao et al.   RADIOTHERAPY AND ONCOLOGY

Distinctive mucositis and feeding-tube dependency in cetuximab plus radiotherapy for head and neck cancer

(2014) T. Yokota et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Severe gastrointestinal bleeding in patients with locally advanced head and neck squamous cell carcinoma treated by concurrent radiotherapy and Cetuximab

(2014) Naoya Murakami et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Bio-radiation dermatitis: the need of a new grading: in regard to Bernier et al: Ann Oncol 2011; 22(10): 2191-2200

(2013) E. G. Russi et al.   ANNALS OF ONCOLOGY

New treatment strategies for HPV-positive head and neck cancer

(2013) B. Kofler et al.   EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY

Phase II Study of Cetuximab Plus Concomitant Boost Radiotherapy in Japanese Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck

(2013) S. Okano et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Induction Chemotherapy Followed by Either Chemoradiotherapy or Bioradiotherapy for Larynx Preservation: The TREMPLIN Randomized Phase II Study

(2013) Jean Louis Lefebvre et al.   JOURNAL OF CLINICAL ONCOLOGY

Deintensification Candidate Subgroups in Human Papillomavirus–Related Oropharyngeal Cancer According to Minimal Risk of Distant Metastasis

(2013) Brian O'Sullivan et al.   JOURNAL OF CLINICAL ONCOLOGY

Management of ‘In-Field' Skin Toxicity in Head and Neck Cancer Patients Treated with Combined Cetuximab and Radiotherapy

(2013) Domenico Cante et al.   ONCOLOGY

Intensity-modulated radiation therapy for head and neck cancer: Systematic review and meta-analysis

(2013) Gustavo Nader Marta et al.   RADIOTHERAPY AND ONCOLOGY

Survival and Prognostic Factors of Different Sites of Head and Neck Cancer: An Analysis from Thailand

(2012) Kowit Pruegsanusak et al.   Asian Pacific Journal of Cancer Prevention

A Dermatitis Control Program (DeCoP) for head and neck cancer patients receiving radiotherapy: a prospective phase II study

(2012) Sadamoto Zenda et al.   International Journal of Clinical Oncology

The comparison between weekly and three-weekly cisplatin delivered concurrently with radiotherapy for patients with postoperative high-risk squamous cell carcinoma of the oral cavity

(2012) Din-Li Tsan et al.   Radiation Oncology

Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: A randomized controlled trial

(2012) Tejpal Gupta et al.   RADIOTHERAPY AND ONCOLOGY

Management of radiation dermatitis in patients receiving cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: proposals for a revised grading system and consensus management guidelines

(2011) J. Bernier et al.   ANNALS OF ONCOLOGY

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

(2011) Christopher M Nutting et al.   LANCET ONCOLOGY

Multicenter phase II study of an opioid-based pain control program for head and neck cancer patients receiving chemoradiotherapy

(2011) Sadamoto Zenda et al.   RADIOTHERAPY AND ONCOLOGY

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

(2009) James A Bonner et al.   LANCET ONCOLOGY

Head and neck cancer in the elderly: An overview on the treatment modalities

(2008) Kostas N. Syrigos et al.   CANCER TREATMENT REVIEWS

Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis

(2008) Mitchell Machtay et al.   JOURNAL OF CLINICAL ONCOLOGY